PhaseBio Pharmaceuticals Inc of Malvern, PA, a company, filed a Form D amendment with the SEC on 2012-06-18. The offering totals $48.5M, of which $48.5M was reported sold. Industry: Biotechnology.
Showing 25 of 28 people.
| Name | Role | Location |
|---|---|---|
| James K Barrett | Director | Baltimore, MD |
| Guy K Fish | Director | Boston, MA |
| Robert K Ingram | Director | Durham, NC |
| Justin K Klein | Director | Chevy Chase, MD |
| Christopher Prior | Director | Raleigh, NC |
| Craig K Rosen | Director | Pasadena, MD |
| Asish K Xavier | Director | New Brunswick, NJ |
| Ashutosh Chilkoti | Executive Officer | Durham, NC |
| Christopher Prior | Executive Officer | Raleigh, NC |
| Clay Thorp | Director | Durham, NC |
| Ashutosh Chilkoti | Director | Durham, NC |
| Jonathan Mow | Director | El Cajon, CA |
| Jonathan Mow | Executive Officer | El Cajon, CA |
| Tyrell Rivers | Director | Chicago, IL |
| Justin Klein | Director | San Carlos, CA |
| Linda Tufts | Director | Cleveland, OH |
| Bibhash Mukhopadhyay | Director | Malvern, PA |
| John Sharp | Executive Officer | Malvern, PA |
| Nancy Hutson | Director | Malvern, PA |
| Caroline Loewy | Director | Malvern, PA |
| Joel Sussman | Executive Officer | Malvern, PA |
| Michael K Gutch | Director | Research Triangle Park, NC |
| Thomas K Laundon | Director | Research Triangle Park, NC |
| Thomas K Laundon | Executive Officer | Research Triangle Park, NC |
| Douglas K Reed | Director | Durham, NC |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2018-09-10 | D | $32.1M | $26.0M |
| 2017-01-31 | D | $7.9M | $6.6M |
| 2015-07-21 | D/A | $42.0M | $21.0M |
| 2015-03-12 | D | $40.0M | $20.0M |
| 2010-12-06 | D/A | $25.3M | $25.3M |
| 2010-01-05 | D | $25.3M | $10.1M |
| 2009-11-12 | D | $1.0M | $1000K |